Literature DB >> 34312922

A review of therapeutic potentials of turmeric (Curcuma longa) and its active constituent, curcumin, on inflammatory disorders, pain, and their related patents.

Bibi Marjan Razavi1,2, Mahboobeh Ghasemzadeh Rahbardar2, Hossein Hosseinzadeh2,3.   

Abstract

Turmeric (Curcuma longa) and its constituent, curcumin, have been used for their therapeutic properties for a long time. Most of the medicinal impacts of turmeric and curcumin might be attributed to their anti-inflammatory, antinociceptive, and antioxidant effects. In the present review, the preventive and therapeutic potentials of turmeric and its active constituent, curcumin, on inflammatory disorders and pain as well as patents related to their analgesic and anti-inflammatory effects, have been summarized to highlight their value on human health. A literature review was accomplished in Google Scholar, PubMed, Scopus, Google Patent, Patentscope, and US Patent. Several documents and patents disclosed the significance of turmeric and curcumin to apply in several therapeutic, medicinal, and pharmaceutical fields. These phytocompounds could be applied as a supplementary therapy in phytotherapy, inflammatory disorders such as arthritis, inflammatory bowel diseases, osteoarthritis, psoriasis, dermatitis, and different types of pain including neuropathic pain. However, because of inadequate clinical trials, further high-quality studies are needed to firmly establish the clinical efficacy of the plant. Consistent with the human tendency to the usage of phytocompounds rather than synthetic drugs, particular consideration must be dedicated to bond the worth of turmeric and curcumin from basic sciences to clinical applications.
© 2021 John Wiley & Sons Ltd.

Entities:  

Keywords:  Curcuma longa; anti-inflammatory; antinociceptive; curcumin; pain; turmeric

Mesh:

Substances:

Year:  2021        PMID: 34312922     DOI: 10.1002/ptr.7224

Source DB:  PubMed          Journal:  Phytother Res        ISSN: 0951-418X            Impact factor:   5.878


  8 in total

1.  The comparison of curcuminoid formulations or its combination with conventional therapies versus conventional therapies alone for knee osteoarthritis.

Authors:  Yingying Wan; Wenting Sun; Jiaxi Yang; Jianxun Ren; Qiuai Kou
Journal:  Clin Rheumatol       Date:  2022-03-16       Impact factor: 2.980

2.  Efficacy and safety of curcuminoids alone in alleviating pain and dysfunction for knee osteoarthritis: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Jie Feng; Zhao Li; Linling Tian; Panyun Mu; Yimei Hu; Feng Xiong; Xu Ma
Journal:  BMC Complement Med Ther       Date:  2022-10-19

3.  ViphyllinTM, a Standardized Black Pepper Seed Extract Exerts Antinociceptive Effects in Murine Pain Models via Activation of Cannabinoid Receptor CB2, Peroxisome Proliferator-Activated Receptor-Alpha and TRPV1 Ion Channels.

Authors:  Karempudi Venkatakrishna; Kuppam Sundeep; Heggar Venkataramana Sudeep; Kuluvar Gouthamchandra; Kodimule Shyamprasad
Journal:  J Pain Res       Date:  2022-02-05       Impact factor: 3.133

Review 4.  Cassia alata, Coriandrum sativum, Curcuma longa and Azadirachta indica: Food Ingredients as Complementary and Alternative Therapies for Atopic Dermatitis-A Comprehensive Review.

Authors:  Yik-Ling Chew; Mei-Ann Khor; Zhao Xu; Sue-Kei Lee; Jing-Wen Keng; Sze-Huey Sang; Gabriel Akyirem Akowuah; Khang Wen Goh; Kai Bin Liew; Long Chiau Ming
Journal:  Molecules       Date:  2022-08-26       Impact factor: 4.927

Review 5.  Review of potential medical treatments for middle ear cholesteatoma.

Authors:  Matthias Schürmann; Peter Goon; Holger Sudhoff
Journal:  Cell Commun Signal       Date:  2022-09-19       Impact factor: 7.525

6.  Curcumin-Based β-Diketo Ligands for Ga3+: Thermodynamic Investigation of Potential Metal-Based Drugs.

Authors:  Matteo Mari; Debora Carrozza; Gianluca Malavasi; Ettore Venturi; Giulia Avino; Pier Cesare Capponi; Michele Iori; Sara Rubagotti; Silvia Belluti; Mattia Asti; Erika Ferrari
Journal:  Pharmaceuticals (Basel)       Date:  2022-07-12

7.  Curcumin and Curcuma longa Extract in the Treatment of 10 Types of Autoimmune Diseases: A Systematic Review and Meta-Analysis of 31 Randomized Controlled Trials.

Authors:  Liuting Zeng; Tiejun Yang; Kailin Yang; Ganpeng Yu; Jun Li; Wang Xiang; Hua Chen
Journal:  Front Immunol       Date:  2022-08-01       Impact factor: 8.786

8.  Curcumin regulates the homeostasis of Th17/Treg and improves the composition of gut microbiota in type 2 diabetic mice with colitis.

Authors:  Qiu-Ping Xiao; You-Bao Zhong; Zeng-Ping Kang; Jia-Qi Huang; Wei-Yan Fang; Si-Yi Wei; Jian Long; Shan-Shan Li; Hai-Mei Zhao; Duan-Yong Liu
Journal:  Phytother Res       Date:  2022-03-02       Impact factor: 6.388

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.